Physician profile
Kevin Tehrani
NPI 1346332301
$8,564.41
in general payments reported to CMS, 2019-2025
20 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,878 · 2020: $29.49 · 2021: $827 · 2022: $2,376 · 2023: $104 · 2024: $121 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Food and Beverage | $654.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $2,542.24 | 2019-2023 | Xeomin |
| Sientra, INC. | $2,450.70 | 2019-2022 | |
| Kci USA, INC. | $959.81 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $800.00 | 2025 | Product In Development |
| Mentor Worldwide LLC | $401.76 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $361.43 | 2019-2022 | |
| Galderma Laboratories, L.P. | $199.87 | 2021 | |
| Abbvie INC. | $157.57 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Davol INC. | $156.00 | 2022 | |
| Motiva USA, LLC | $153.09 | 2025 | |
| Smith+Nephew, INC. | $113.57 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $70.61 | 2024-2025 | |
| Medtronic, INC. | $44.54 | 2022 | |
| Solventum Corporation | $36.21 | 2025 | Prevena Restor Bellaform, Prevena |
| Integra Lifesciences Corporation | $23.95 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $21.42 | 2023 | Exparel |
| Acelrx Pharmaceuticals, INC. | $20.90 | 2022 | |
| Apyx Medical Corporation | $18.18 | 2019 | |
| Convatec INC. | $16.31 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $16.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Tehrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.